Your browser doesn't support javascript.
(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins.
Green, Douglas R; Thomas, Paul G.
  • Green DR; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Thomas PG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Sci Adv ; 8(34): eade3956, 2022 Aug 26.
Article in English | MEDLINE | ID: covidwho-2001756
ABSTRACT
Improved adenovirus-based COVID-19 vaccines provide an important tool to combat the ever-evolving virus.

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.ade3956

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.ade3956